A5005498552- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
- Infective Endocarditis Diagnosis and Management
- Cardiac pacing and defibrillation studies
- Cardiac Imaging and Diagnostics
- Cardiac and Coronary Surgery Techniques
- Diabetes Treatment and Management
- Cardiac Structural Anomalies and Repair
- Diabetes Management and Research
- Pulmonary Hypertension Research and Treatments
- Chronic Kidney Disease and Diabetes
- Cardiovascular Effects of Exercise
- Mechanical Circulatory Support Devices
- Metabolism, Diabetes, and Cancer
Heart and Diabetes Center North Rhine-Westphalia
2022-2025
Bielefeld University
2024-2025
Ruhr University Bochum
2023
As transcatheter aortic valve replacement is performed increasingly in younger, low-risk patients, the need for commissural alignment and coronary access has increased. Design elements of JenaValve Trilogy (JVT) heart (THV) ensure both. This study sought to evaluate outcome patients with stenosis (AS) treated this novel transfemoral, self-expanding THV. We included 43 consecutive severe AS JVT system at 5 German sites. The primary endpoint was technical success procedure. Procedural...
Background The tricuspid annular plane systolic excursion (TAPSE) assessed by echocardiography has failed in predicting outcomes patients with severe regurgitation (TR) undergoing transcatheter valve intervention (TTVI). Considering the complex shape of annulus and right ventricle, as well difficult echocardiographic image acquisition heart, cardiac computed tomography (CT) might be superior for analysis excursion. Thus, this study aimed to analyze whether CT-captured TAPSE provides...
Interventionelle Behandlungsstrategien haben das Therapiespektrum für Patienten mit atrioventrikulären (AV) Klappeninsuffizienzen (Mitral- und Trikuspidalklappe) deutlich erweitert. Mittlerweile gibt es gute Evidenz, dass interventionelle Verfahren sicher durchgeführt werden können effektiv in der Reduktion Insuffizienzen sind. Der erste Teil dieses Artikels befasst sich Evaluation von AV-Klappen-Insuffizienzen Indikation eine Therapiestrategie. Im zweiten nun die gängigen interventionellen...
Abstract Aims Transcatheter tricuspid edge-to-edge repair (T-TEER) has gained widespread use for the treatment of regurgitation (TR) in symptomatic patients with high operative risk. Although secondary TR is most common pathology, some exhibit primary or predominantly TR. Characterization these pathologies T-TEER context not been systematically performed. Methods and results Patients assigned to by interdisciplinary heart team were consecutively recruited two European centres over 4 years....
Interventionelle Behandlungsstrategien haben das Therapiespektrum für Patienten mit atrioventrikulären (AV) Klappeninsuffizienzen (Mitral- und Trikuspidalklappe) deutlich erweitert. Mittlerweile gibt es gute Evidenz, dass interventionelle Verfahren sicher durchgeführt werden können effektiv in der Reduktion Insuffizienzen sind. Dabei lindern sie die Symptome Patienten, reduzieren Hospitalisierungsrate aufgrund von kardialen Dekompensationen führen zu einer Steigerung Lebensqualität. Der...
Abstract Background Transcatheter tricuspid valve intervention (TTVI) has shown promising results with persistent reduction of regurgitation (TR) and improvements in functional class quality life (QOL). Objectives To analyze the impact TTVI on maximal submaximal exercise capacity (SEC). Methods Constant work-rate exercise-time (CWRET) testing reflects SEC, which is more likely to be relevant for daily activities provides differentiated physiological insight into nature intolerance. Thus, 30...
Transcatheter mitral valve interventions (TMVI) have been proven to reduce symptom burden and improve outcomes in patients with severe regurgitation (MR). However, the impact of right ventricular function (RVF) on exercise capacity MR is less well understood.
Up to 30% of patients with the left ventricular assist device (LVAD) develop moderate severe aortic regurgitation (AR) within first year. Surgical valve replacement (SAVR) is treatment choice in native AR. However, high perioperative risk LVAD might prohibit surgery and therapy challenging.We report on a 55-year-old female patient AR 15 months after implantation due advanced heart failure (HF) as consequence ischaemic cardiomyopathy. was discarded surgical risk. Thus, decision made evaluate...
Background/Objectives: To investigate the role of right ventricular (RV) function on exercise capacity in patients undergoing transcatheter mitral valve repair (TMVR) we aimed to perform cardiopulmonary testing (CPET) and show a correlation between an improved RV maximal submaximal capacity. Methods: Constant work rate time (CWRET) reflects submaximal/endurance capacity, which is more likely be relevant for daily life activities, gives differentiated physiologic insight into nature...